Specifically, we found that the pathological tumor response to chemoradiation was significantly reduced in tumors with low- versus high- prelamin A level in pre-treatment biopsy tissues; likewise, high RAD51 was associated with a significantly lower rate of pathological complete response compared to tumors with low expression. Here, RAD51 is linked to neoplasm.